All Insights
"Need to know" | Leveraged Finance Market Update
Welcome to the latest edition of Need to Know, Osborne Clarke's Leveraged Finance Market Update, offering a bite-size guide to
Assessing the impact of COVID-19 on EBITDA: EBITDAC
For businesses looking to satisfy financial covenants in difficult conditions, as well as those looking to re-finance, the interpretation of
Loan transfer provisions: assign of things to come
The ability for a lender to trade out of a loan position is a trademark of the syndicated loan markets
Supreme Court's criteria on the subjection to the AJD (Actos Jurídicos Documentados) (stamp duty) of the release of co-debtors from a mortgage loan
The Supreme Court established in its Judgment of 20 May 2020 (STS 521/2020) the criteria for submission to the AJD
Funds Legal Update | 25 September 2020
With new rules and guidance coming into force later this month, we take a look at the key dates for
Singapore's competition regulator sets out new guidelines on price transparency
The Competition and Consumer Commission of Singapore (CCCS) has published its Guidelines on Price Transparency that set out how it
Financial Conduct Authority drives change for vulnerable customers
The regulator believes there is room for improvement in the way UK financial services treat vulnerable customers and its new
Has Covid-19 made IRR an irrelevant measure of success?
As confidence starts to return to the market, fund managers and investors are assessing the financial effects of the Covid-19
Funds Legal Update | 26 August 2020
As far as the investment funds industry is concerned, August has been far from the usual summer lull.
Work-pass requirements tightened again for non-Singaporeans
Increase in minimum salary requirements with special focus on financial sector comes amid growing public concern over a weakened job
Singapore proposes amendments to Companies Act
Regulator looks to update Singapore's corporate regime to reflect global legislative, economic and technological developments and to strengthen competiveness
Life sciences companies turn to public markets for injections of capital
London markets have remained open during the pandemic allowing for a surge in life sciences and healthcare sector deals including